InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by CLACKSON TIMOTHY P, Directeur, Président et CEO. Insider active across 4 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 11 reports have been published. Split: 3 buys · 1 sell. Total volume traded: €62k. Activity tracked since 17 June 2021. The latest transaction was disclosed on 1 September 2023 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
15,777 shares0Common StockSEC:0001415889-23-012907:0
2,500 shares@ US$6.79827.0% of flowCommon StockSEC:0001104659-22-118549:0
Ideal exit: 8 Aug 2023 (T+270)
23,590 sharesCommon StockSEC:0000899243-22-033647:0
31,553 shares0Common StockSEC:0001209191-22-038758:0
4,500 shares0Common StockSEC:0000899243-22-021662:0
2,600 shares@ US$9.762150.0% of flowCommon StockSEC:0000899243-21-049429:0
Ideal exit: 17 Sept 2022 (T+270)
2,600 shares@ US$9.762136.5% of flowCommon StockSEC:0000899243-21-049429
Ideal exit: 17 Sept 2022 (T+270)
2,750 shares0Common StockSEC:0000899243-21-025092
2,750 shares0Common StockSEC:0000899243-21-025092:0
29,333 sharesCommon StockSEC:0001127602-16-039317:0
14,667 sharesCommon StockSEC:0001127602-16-039317:1
11 of 11 declarations
About CLACKSON TIMOTHY P
Timothy P. Clackson is Director, President and CEO at Forma Therapeutics Holdings, Inc., Theseus Pharmaceuticals, Inc., and Elevation Oncology, Inc. In this role, he oversees the strategic and operational direction of these companies. Timothy brings extensive experience in the biopharmaceutical sector, contributing to the growth and innovation of these firms.
